HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

BJ-2266

downregulates the JAK/STAT signaling pathway; structure in first source

Also Known As:

N-((5-hydroxy-3,4,6-trimethylpyridin-2-yl)carbamothioyl)benzamide

Networked: 1 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Chang, Jae-Hoon: 1 article (01/2017)
2.	Jeong, Byeong-Seon: 1 article (01/2017)
3.	Timilshina, Maheshwor: 1 article (01/2017)
4.	You, Zhiwei: 1 article (01/2017)

Related Diseases

1.	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/01/2017 - "BJ-2266 ameliorates experimental autoimmune encephalomyelitis through down-regulation of the JAK/STAT signaling pathway." 01/01/2017 - "We assessed the inhibitory effect of BJ-2266 in experimental autoimmune encephalomyelitis (EAE). "
2.	Disease Progression 01/01/2017 - "Our results suggest that BJ-2266 treatment significantly suppresses EAE disease progression with reduced generation of Th1 and Th17 cells. "